CD80 and cancer: It was demonstrated that Bio‐MVs formulation with CD80 expression cells could control tumor growth because this kind of biomimetic nanoformulation can directly present the model antigen to cancer‐specific T cells without the need for professional antigen‐presenting cells (APC).